Seven Eight Capital’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,742
| Closed | -$786K | – | 680 |
|
|
2024
Q3 | $786K | Sell |
10,742
-11,168
| -51% | -$817K | 0.07% | 465 |
|
|
2024
Q2 | $1.5M | Buy |
+21,910
| New | +$1.5M | 0.16% | 219 |
|
|
2023
Q3 | – | Sell |
-6,625
| Closed | -$419K | – | 782 |
|
|
2023
Q2 | $419K | Sell |
6,625
-7,030
| -51% | -$445K | 0.07% | 345 |
|
|
2023
Q1 | $739K | Buy |
+13,655
| New | +$739K | 0.15% | 184 |
|
|
2022
Q3 | – | Sell |
-6,219
| Closed | -$355K | – | 663 |
|
|
2022
Q2 | $355K | Sell |
6,219
-4,504
| -42% | -$257K | 0.14% | 226 |
|
|
2022
Q1 | $656K | Buy |
+10,723
| New | +$656K | 0.09% | 274 |
|
|
2020
Q2 | – | Sell |
-30,100
| Closed | -$463K | – | 594 |
|
|
2020
Q1 | $463K | Buy |
+30,100
| New | +$463K | 0.12% | 230 |
|